|
Obstetrical outcome among BV patients after treatment with clindamycin |
||||||||||
| Obstetric outcome |
BV |
No BV |
Missing |
|||||||
| Effect of treatment |
Yes |
All BV |
% |
Yes |
All No BV |
% |
Total |
|||
|
|
||||||||||
| Instrument delivery |
64 |
816 |
7.8 |
631 |
7945 |
7.9 |
30 |
OR 1.0 (95% CI 0.8–1.3) |
8791 |
|
| Treated BV vs. not treated BV |
34 |
407 |
8.4 |
OR 0.9 (95% CI 0.6–1.3) |
816 |
|||||
| Cesarean delivery |
107 |
816 |
13.1 |
1124 |
7945 |
14.1 |
30 |
OR 0.9 (95% CI 0.7–1.1) |
8791 |
|
| Treated BV vs. not treated BV |
52 |
407 |
12.8 |
OR 0.9 (95% CI 0.7–1.3) |
816 |
|||||
| Preeclampsia |
36 |
816 |
4.4 |
304 |
7945 |
3.8 |
30 |
OR 1.2 (95% CI 0.8–1.7) |
8791 |
|
| Treated BV vs. not treated BV |
17 |
407 |
4.2 |
OR 1.2 (95% CI 0.7–1.9) |
816 |
|||||
| Early rupture of membranes |
43 |
816 |
5.3 |
391 |
7945 |
4.9 |
30 |
OR 1.1 (95% CI 0.8–1.5) |
8791 |
|
| Treated BV vs. not treated BV |
24 |
407 |
5.9 |
OR 0.9 (95% CI 0.6–1.5) |
816 |
|||||
| SGA |
49 |
815 |
6.0 |
374 |
7920 |
4.7 |
56 |
OR 1.3 (95% CI 0.95–1.8) |
8791 |
|
| Treated BV vs. not treated BV |
21 |
407 |
5.2 |
OR 1.4 (95% CI 0.98–2.2) |
815 |
|||||
| 5 min. |
22 |
819 |
2.7 |
191 |
7972 |
2.4 |
0 |
OR 1.1 (95% CI 0.7–1.8) |
8791 |
|
| Treated BV vs. not treated BV |
7 |
407 |
1.7 |
OR 1.5 (95% CI 0.9–2.6) |
819 |
|||||
| Gender = Female |
379 |
815 |
46.5 |
3846 |
7933 |
48.5 |
43 |
OR 0.9 (95% CI 0.8–1.1) |
8791 |
|
Larsson et al. BMC Women's Health 2007 7:20 doi:10.1186/1472-6874-7-20 |
||||||||||